Status epilepticus management and mortality risk factors: a retrospective study

Neurologia (Engl Ed). 2022 Sep;37(7):532-542. doi: 10.1016/j.nrleng.2019.06.009. Epub 2021 Sep 11.

Abstract

Introduction: Status epilepticus (SE) is a neurological emergency with relatively high mortality rates. In this study, we analysed the management of SE and identified mortality risk factors that may be addressed with educational interventions or modifications to hospital protocols.

Methods: In this retrospective study, we analysed demographic, treatment, and outcome data from 65 patients (mean age, 59 years [range, 44.5-77]; 53.8% women) who were admitted to our tertiary hospital during an 18-month period and met the 2015 International League Against Epilepsy criteria for SE.

Results: Thirty patients (46.2%) had history of epilepsy. The most frequent causes of SE were cerebrovascular disease (27.7%) and systemic infection (16.9%). The following deviations were observed in the administration of the antiepileptic drugs: benzodiazepines were used as first option in only 33 (50.8%) patients; the combination of 2 benzodiazepines was recorded in 7 cases (10.8%); and lacosamide was used as an off-label drug in 5 patients (7.7%). Electroencephalography studies were performed in only 26 patients (40%); and only 5 studies (7.7% of patients) were performed within 12 hours of seizure onset. The mortality rate was 21.5%. Acute stroke and cerebrovascular complications were associated with higher mortality rates, while previous history of epilepsy and admission to intensive care were related to better prognosis (P < .05).

Conclusions: To improve SE management and reduce mortality rates, training activities targeting emergency department physicians should be implemented, together with elective intensive care admission for patients with multiple mortality risk factors (eg, absence of history of epilepsy, acute stroke, or cardiovascular complications).

Keywords: Acute complications; Antiepileptic drugs; Complicaciones agudas; Epilepsia; Epilepsy; Estatus epiléptico; Factores de riesgo; Fármacos antiepilépticos; Mortalidad; Mortality; Risk factors; Status epilepticus.

MeSH terms

  • Benzodiazepines / therapeutic use
  • Epilepsy* / drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Off-Label Use
  • Retrospective Studies
  • Status Epilepticus* / drug therapy
  • Status Epilepticus* / etiology
  • Stroke* / complications

Substances

  • Benzodiazepines